Advertisement

Acute Thyroid and Adrenal Disorders

  • P. E. Rama Subrahmanyam
Chapter

Abstract

Acute thyroid disorders are infrequently observed in clinical practice with a poorly defined incidence. They represent a long-standing dysregulation of thyroid gland, usually precipitated by an acute illness. They are either caused by overt dysfunction resulting in myxoedema coma or hyperfunctioning of the gland giving rise to thyrotoxicosis. Despite utmost care, mortality remains high, 30–50 % in myxoedema coma and 30–40 % in thyroid storm thereby necessitating immediate and aggressive intervention in emergency department.

Keywords

Thyroid Hormone Pituitary Adenoma Adrenal Insufficiency Basal Metabolic Rate Adrenal Crisis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gavin LA. Thyroid crises. Med Clin N Am. 1991;75:179–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Tietgens ST, Leinung MC. Thyroid storm. Med Clin N Am. 1995;79:169–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Wartofsky L. Thyrotoxic storm. In: Braverman L, Utiger R, editors. Werner & Ingbar’s the thyroid. 9th ed. Philadelphia: Williams & Wilkins; 2005. p. 651–7.Google Scholar
  4. 4.
    Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263–77.Google Scholar
  6. 6.
    Akin F, Yaylali GF, Bastemir M. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients. Med Princ Pract. 2008;17(2):167.CrossRefPubMedGoogle Scholar
  7. 7.
    Wartofsky L. Thyrotoxic storm. In: Braverman LE, Utiger RD, editors. Werner’s & Ingbar’s the thyroid, 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.Google Scholar
  8. 8.
    Rodríguez I, Fluiters E, Pérez-Méndez LF, Luna R, Páramo C, García-Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347–50.CrossRefPubMedGoogle Scholar
  9. 9.
    Dutta P, Bhansali A, Masoodi S, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 1081.Google Scholar
  11. 11.
    Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med. 1988;84(5):877–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Wilson WR, Bedell GN. The pulmonary abnormalities in myxedema. J Clin Invest. 1960;39:42–55.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med. 1964;36(6):876–82.CrossRefPubMedGoogle Scholar
  14. 14.
    Reinhardt W, Mann K. Incidence, clinical picture, and treatment of hypothyroid coma: results of a survey. Med Klin. 1997;92:521–4.CrossRefGoogle Scholar
  15. 15.
    Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab. 2004;89:281–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Bansal V, Asmar NE, Selman WR, Arafah BM. Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg Focus. 2015;38(2), E4.CrossRefPubMedGoogle Scholar
  17. 17.
    Ragnarsson O, Johannsson G. Cushing’s syndrome: a structured short- and long-term management plan for patients in remission. Eur J Endocrinol. 2013;169:R139–52.CrossRefPubMedGoogle Scholar
  18. 18.
    Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.CrossRefPubMedGoogle Scholar
  19. 19.
    Van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA. Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) 2013;78:481–88. Fernández-Rodríguez E, et al. Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing’s syndrome. Endocrinol Metabol. 2008;52(6):1066–70.Google Scholar
  20. 20.
    Soh LM, Gunganah K, Akker SA, Jones P, Khachi H, Dodzo K, Drake WM. Etomidate in the emergency management of hypercortisolemia. Eur J Endocrinol. 2012;167(5):727–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Colao A, Petersenn S, et al. A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med. 2012;366:914–24.CrossRefPubMedGoogle Scholar
  22. 22.
    Nieman LK. Update in the medical therapy of Cushing’s disease. Curr Opin Endocrinol Diabetes Obes. 2013;20:330–4.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes. J Intern Med. 2009;266:19–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Manger W, Gifford RJ. Pheochromocytoma: a clinical review. In: Laragh J, Brenner B, editors. Hypertension: pathophysiology, diagnosis, and management, vol. 2. 2nd ed. New York: Raven Press; 1995. p. 2225–44.Google Scholar
  25. 25.
    Mazzaglia PJ. Hereditary pheochromocytoma and paraganglioma. J Surg Oncol. 2012;106:580–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Canu L, Rapizzi E, Zampetti B, et al. Pitfalls in genetic analysis of pheochromocytomas/paragangliomas – case report. J Clin Endocrinol Metab. 2014;99:2321–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Mariucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014;38:7–41.CrossRefGoogle Scholar
  28. 28.
    Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Sloand EM, Thompson BT. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984;144:173–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Emergency MedicineLeicester Royal Infirmary, NHS, UKLetchworth Garden CityUK

Personalised recommendations